Compare Stryker Corporation (SYK) vs Vanguard Dividend Appreciation Index Fund ETF (VIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? Stryker Corporation trades at $277.44 (market cap $105.63B), while Vanguard Dividend Appreciation Index Fund ETF trades at $239.88. The key difference: Stryker Corporation pays a 1.28% dividend while Vanguard Dividend Appreciation Index Fund ETF pays none, and Vanguard Dividend Appreciation Index Fund ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.
| SYK | VIG | |
|---|---|---|
Market Cap | $105.63B | — |
Sector | Technology | — |
52-Week High | $388.79 | $246.61 |
52-Week Low | $275.39 | $210.70 |
Enterprise Value | $117.10B | — |
Dividend Yield | 1.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker Corporation (SYK) trades at $276.43, down 8.81% over 24 hours, reflecting bearish technical signals but strong fundamentals. The stock shows robust profitability with a 14.43% net income margin and consistent earnings beats in recent quarters. Recent developments include the launch of an FDA-cleared surgical app for Apple Vision Pro and the acquisition of ZuriMED to expand shoulder care offerings. Analyst consensus remains strongly bullish with a $372.89 price target, though ongoing securities fraud investigations pose near-term sentiment risks.
Outlook is positive long-term due to solid financial health, innovation pipeline, and institutional support, but investors face volatility from legal probes and technical bearishness. The stock's current dip may present a buying opportunity for those confident in Stryker's market position and growth trajectory, balanced against regulatory and market risks.
VIG trades at $240.11, down 0.79% on the day, with a bearish technical signal from moving averages but neutral oscillators. The ETF focuses on dividend growth, with a dividend of $1.00 scheduled for June 2026. Recent news highlights its role in retirement portfolios and comparisons with peers like SCHD and DGRO, emphasizing its defensive tech exposure and lower yield strategy.
The outlook for VIG hinges on its dividend growth approach amid market volatility. Opportunities include steady income appeal for long-term investors, while risks involve underperformance if high-yield alternatives gain favor or economic conditions pressure dividend sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About Vanguard Dividend Appreciation Index Fund ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →
